Results 231 to 240 of about 10,148,101 (391)

Clinical types and drug therapy of renal impairment in cirrhosis

, 1975
Joan Rodés, J. Bosch, Vicente Arroyo
openalex   +1 more source

348 DEGREE OF INDICATION OF DRUG THERAPY IN NEONATES [PDF]

, 1978
Jacob V. Aranda, Ana Portuguez-Malavasi, Judi Collinge   +2 more
openalex   +1 more source

Targeting carbonic anhydrase IX/XII prevents the anti‐ferroptotic effect of stromal lactic acid in prostate carcinoma

Molecular Oncology, EarlyView.
In prostate carcinoma, lactic acid, secreted by highly glycolytic cancer‐associated fibroblasts, is imported into tumor cells through the MCT1 transporter and prevents RSL3 and erastin‐induced ferroptosis (A). Targeting of carbonic anhydrase IX/XII, the main extracellular pH regulators, in tumor and stromal cells reduces microenvironmental acidosis and
Elisa Pardella, Giuseppina Comito, Luigi Ippolito, Erica Pranzini, Marta Iozzo, Giulia Gangarossa, Francesca Virgilio, Silvia Bua, Alessio Nocentini, Giada Sandrini, Nicla Lorito, Marina Bacci, Gabriella Nesi, Pietro Spatafora, Sergio Serni, Claudiu T. Supuran, Andrea Morandi, Paola Chiarugi, Elisa Giannoni   +18 more
wiley   +1 more source

Gingival hyperplasia and folic acid deficiency from anticonvulsive drug therapy A theoretical relationship

, 1977
Richard I. Vogel
openalex   +1 more source

Clinical and Endoscopic Study of Gastric Lesion in Patients taking and Anti-tuberculous Drug Therapy [PDF]

, 1979
Yoon Jung Huh
openalex   +1 more source

The critical role of DNA damage‐inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation

Molecular Oncology, EarlyView.
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li, Zhijie Cao, Haiyan Xing, Zhenya Xue, Wenbing Liu, Jiayuan Chen, Yihan Mei, Runxia Gu, Hui Wei, Shaowei Qiu, Min Wang, Qing Rao, Jianxiang Wang   +12 more
wiley   +1 more source

Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease. [PDF]

Gut Microbes
Zhang Y, Mo C, Ai P, He X, Xiao Q, Yang X.   +5 more
europepmc   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

Evaluation of the Efficacy, Safety, and Adherence to Oral Drug Therapy in Patients with Relapsing-Remitting Multiple Sclerosis. [PDF]

Medicina (Kaunas)
Sėdžius P, Musneckienė D.
europepmc   +1 more source

Drugs for Combined Therapy Experimental Studies on the Antileprosy Activity of Ethionamide and Prothionamide, and a General Review

, 1978
M. Joseph Colston, G.A. Ellard, Patricia T. Gammon   +2 more
openalex   +1 more source